Brislin promoted to Vice President of Quantum Rehab
New role sees longtime Pride player strengthen relationships, partnerships and products.
- By David Kopf
- Mar 15, 2012
Pride Mobility Products Crop. and Quantum Rehab have promoted of Jay Brislin to Vice President of Quantum Rehab. Brislin’s new role will be to continue strengthening Quantum Rehab’s sales relationships with providers and clinicians, implementing strong clinical development strategies, establishing collaborative product development partnerships with industry professionals, setting product development priorities for all Quantum brands, and continued quality and operational support.
“I’m very excited and appreciative of this opportunity,” Brislin said. “I am also very thankful to those who have helped with my growth at Pride over the last 11-plus years. I’m extremely lucky to be a part of the Quantum Team that has a lot of talented people who are dedicated to providing exceptional quality, products, support, and customer trust that enhances the lives of the clients using our products.”
“Jay has a unique, collaborative consumer centric approach to Quantum Rehab,” Pride Chairman and CEO Scott Meuser said. “This allows him to give our Research and Development Team strong direction regarding product advancement priorities. Jay’s strong relationships with providers and clinicians has also allowed Quantum to build multiple options and accessories with consumers in mind. Most importantly, Jay has the qualities needed to continue to advance, strengthen and grow the Quantum Rehab division.”
With a master’s degree in physical therapy, Brislin began his career with Pride Mobility in July 2000 as an Inside Quantum Sales Specialist. In March of 2002, he joined the Quantum Education Department, and in 2004, Brislin was promoted to General Manager of Rehab Applications and Custom Rehab. In 2010, Brislin was promoted to Director, Quantum Product and Clinical Development. As Director, he added manual wheelchairs and Synergy Cushions and Backs to his R&D validations and beta testing responsibilities as well as oversight of National Quantum Rehab Sales. In July of 2011, Brislin also accepted responsibility for the Q-Logic R&D Team.
David Kopf is the Publisher and Executive Editor of HME Business and DME Pharmacy magazines. Follow him on Twitter at @postacutenews.